US 10449182
Sorafenib derivatives as p21 inhibitors
granted A61KA61K31/17A61K31/196
Quick answer
US patent 10449182 (Sorafenib derivatives as p21 inhibitors) held by The Regents of the University of California expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/17, A61K31/196, A61K31/277, A61K31/44